Management of Hypertension
The management of hypertension should follow a stepped approach, starting with lifestyle modifications for all patients, followed by pharmacological therapy with ACE inhibitors, ARBs, calcium channel blockers, or thiazide diuretics as first-line medications, targeting blood pressure below 140/90 mmHg for most patients and 130/80 mmHg for high-risk individuals. 1
Blood Pressure Thresholds for Treatment
When to Initiate Drug Treatment
- Initiate antihypertensive drug treatment if:
Blood Pressure Targets
General population:
High-risk patients (diabetes, chronic renal disease, established cardiovascular disease):
Older patients (≥65 years):
Lifestyle Modifications
Lifestyle modifications should be implemented for all patients with hypertension and those with borderline or high-normal blood pressure 2, 1:
Physical Activity:
Weight Management:
- Target BMI of 20-25 kg/m²
- Waist circumference <94 cm in men and <80 cm in women 1
Dietary Modifications:
- Salt restriction to 5-6 g per day
- Increased consumption of vegetables, fruits, fish, nuts, and unsaturated fatty acids
- Low consumption of red meat
- Low-fat dairy products 1
Alcohol Limitation:
- Men: <14 units/week
- Women: <8 units/week 1
Smoking Cessation for all patients with hypertension 1
Pharmacological Therapy
First-Line Medications
For most patients without compelling indications for other drugs, first-line therapy includes:
Treatment Algorithm
Initial Therapy:
- For BP <160/100 mmHg: Start with monotherapy
- For BP ≥160/100 mmHg or high CV risk: Start with low-dose combination therapy of two drugs 1
If BP Not at Target:
- Increase to full-dose monotherapy OR
- Add a second agent from a different class 1
If Still Not Controlled:
- Triple therapy: Usually combining an ACE inhibitor/ARB + calcium channel blocker + thiazide diuretic 1
Resistant Hypertension:
Monitoring and Follow-up
- Regular follow-up appointments until target BP is achieved (typically monthly)
- Home BP monitoring to detect white coat hypertension and monitor treatment effectiveness
- Ambulatory BP monitoring when clinic readings show unusual variability
- Monitor for medication side effects and adherence
- Check renal function and potassium within 1-2 weeks of initiation for patients on ACE inhibitors or ARBs 1
Special Considerations
Secondary Hypertension Evaluation
Consider evaluation when:
- Sudden onset or worsening of hypertension
- Resistance to multidrug regimen (≥3 drugs)
- Young age (any hypertension <20 years; needing treatment <30 years)
- Clinical clues suggesting secondary causes 2, 1
Improving Adherence
- Simplify regimens when possible (once-daily dosing or fixed-dose combinations)
- Effective behavioral and motivational strategies 2, 1
- Consider cultural, social, and economic factors that may influence adherence 2
Additional Cardiovascular Risk Reduction
- Aspirin: 75 mg daily for secondary prevention and primary prevention in patients >50 years with controlled BP (<150/90 mmHg) and 10-year CVD risk ≥20% 2
- Statins: For all patients with hypertension complicated by cardiovascular disease and for primary prevention in those with 10-year CVD risk ≥20% 2
Most patients with hypertension will require at least two blood pressure-lowering drugs to achieve recommended goals. When no disadvantages of cost exist, fixed drug combinations are recommended to improve adherence 2, 1, 3.